Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-25T09:41:07.691Z Has data issue: false hasContentIssue false
  • English
  • Français

Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments – CORRIGENDUM

Published online by Cambridge University Press:  30 March 2011

Qian Tao  and
Anthony T.C. Chan
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Corrigendum
Information
Expert Reviews in Molecular Medicine , Volume 13 , March 2011 , e10
Copyright
Copyright © Cambridge University Press 2011

In the review by Q. Tao and A.T.C. Chan (Ref. Reference Tao and Chan1), two percentages were given incorrectly in the second paragraph of the section ‘Histology of NPC’, starting on page 4 of the pdf. The first sentence of this paragraph should have read as follows (with the corrected percentages underlined here):

The World Health Organization (WHO) classification system (1978) acknowledges three types of NPC based on the differentiation status of tumour cells: type I, differentiated, keratinising squamous cell carcinoma (75% of NPCs in North America; ~2% of NPCs in southern China) (Refs 11, 12); type II, nonkeratinising carcinoma (12% of NPCs in North America; ~3% of NPCs in southern China); and type III, undifferentiated carcinoma (13% of NPCs in North America; 95% of NPCs in southern China).

References

1Tao, Q. and Chan, A.T.C. (2007) Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Reviews in Molecular Medicine 9, Issue 12, DOI: 10.1017/S1462399407000312CrossRefGoogle ScholarPubMed